Helena W. Rodbard - Concepedia

Author

Helena W. Rodbard

Also Known As

Chang, Annette M., H Rodbard, H. Rodbard, H. W. Rodbard, H.-W. Rodbard, H.W. Rodbard, HELENA W RODBARD, HELENA W. RODBARD, Helena Rodbard, Helena W Rodbard

166

Publications

12.2K

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)The University of Texas Southwestern Medical Center University of North Carolina at Chapel Hill Clinical Research Consultants (United States)Clinical Research Institute

About

Helena W. Rodbard is an author at Novo Nordisk (Denmark) specializing in medicine, diabetes, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	27	6.3K
2	Public Health	11	12	4.1K
3	Health Sciences	5	5	278
4	Nursing	2	2	80
5	Education	1	1	44

Helena W. Rodbard

Publications

Citations

H-Index

Page 1

	Year	Citations
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control Helena W. Rodbard, Paul S. Jellinger, Jaime A. Davidson, Endocrine Practice Metabolic SyndromeDiabetes ManagementEndocrinology Consensus PanelHealth PolicyDiabetes	2009	945
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism H. Jack Baskin, Rhoda H. Cobin, Daniel S. Duick, Endocrine Practice American AssociationIodine Deficiency DisordersThyroid DiseaseThyroid DisordersClinical Practice	2002	672
American Association of Clinical Endocrinologists Medical Guidelines For Clinical Practice For The Prevention and Treatment of Postmenopausal Osteoporosis: 2001 Edition, With Selected Updates For 2003 Stephen F. Hodgson, Nelson B. Watts, John P. Bilezikian, Endocrine Practice Bone DiseaseBone HealthAmerican AssociationMedicineGynecology	2003	605
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis Paul S. Jellinger, Donald A. Smith, Adi Mehta, Endocrine Practice Metabolic SyndromeHealth PolicyCardiovascular DiseaseAmerican AssociationClinical Endocrinologists	2012	537
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial Helena W. Rodbard, Julio Rosenstock, Luís Henrique Santos Canani, Diabetes Care	2019	414
AACE/AAES MEDICAL/SURGICAL Guidelines for Clinical Practice: Management of Thyroid Carcinoma Rhoda H. Cobin, Hossein Gharib, Donald A. Bergman, Endocrine Practice Surgical OncologyMedicineThyroid DiseaseEndocrine SurgerySurgery	2001	370
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hypogonadism in Adult Male Patients—2002 Update Steven M. Petak, Howard R. Nankin, Richard F. Spark, Endocrine Practice InfertilityUrologyAndrologyFertilityAmerican Association	2002	369
Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial Helena W. Rodbard, Ildiko Lingvay, John H. Reed, The Journal of Clinical Endocrinology & Metabolism	2018	353
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes Stephen Gough, Bruce W. Bode, Vincent Woo, The Lancet Diabetes & Endocrinology Diabetes ManagementInsulin DegludecDiabetesPharmacologyClinical Trials	2014	351
Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Bernard Zinman, Athena Philis‐Tsimikas, Bertrand Cariou, Diabetes Care	2012	333

Page 1